Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer

• Natalia Palazón‑Carrión,
• Carlos Jiménez‑Cortegana,
• M. Luisa Sánchez‑León,
• Fernando Henao‑Carrasco,
• Esteban Nogales‑Fernández,
• Massimo Chiesa,
• Rosalía Caballero,
• Federico Rojo,
• María‑Adoración Nieto‑García,
• Víctor Sánchez‑Margalet,
• Luis de la Cruz‑Merino,
• the Spanish Breast Cancer Group (GEICAM) and the Spanish Group for Immunobiotherapy of Cancer (GÉTICA)

Affiliations

Natalia Palazón‑Carrión

Clinical Oncology Department, Virgen Macarena University Hospital

Carlos Jiménez‑Cortegana

Department of Medical Biochemistry and Molecular Biology, and Immunology, School of Medicine, Virgen Macarena University Hospital, University of Seville

M. Luisa Sánchez‑León

Clinical Oncology Department, Virgen Macarena University Hospital

Fernando Henao‑Carrasco

Clinical Oncology Department, Virgen Macarena University Hospital

Esteban Nogales‑Fernández

Clinical Oncology Department, Virgen Macarena University Hospital

Massimo Chiesa

GEICAM (Spanish Breast Cancer Research Group)

Rosalía Caballero

GEICAM (Spanish Breast Cancer Research Group)

Federico Rojo

Pathology Department, IIS-Fundación Jimenez Diaz-CIBERONC

María‑Adoración Nieto‑García

Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Seville

Víctor Sánchez‑Margalet

Department of Medical Biochemistry and Molecular Biology, and Immunology, School of Medicine, Virgen Macarena University Hospital, University of Seville

Luis de la Cruz‑Merino

Clinical Oncology Department, Virgen Macarena University Hospital

the Spanish Breast Cancer Group (GEICAM) and the Spanish Group for Immunobiotherapy of Cancer (GÉTICA)